Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA008720 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA008720, RRID:AB_1844978
- Product name
- Anti-AREG
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AREG, Gene description: amphiregulin, Alternative Gene Names: AREGB, SDGF, Validated applications: IHC, Uniprot ID: P15514, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells.
Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
Melderis S, Hagenstein J, Warkotsch MT, Dang J, Herrnstadt GR, Niehus CB, Neumann K, Panzer U, Berasain C, Avila MA, Tharaux PL, Tiegs G, Steinmetz OM
Journal of the American Society of Nephrology : JASN 2020 Sep;31(9):1996-2012
Journal of the American Society of Nephrology : JASN 2020 Sep;31(9):1996-2012
Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing
Alamri A, Liu X, Blancato J, Haddad B, Wang W, Zhong X, Choudhary S, Krawczyk E, Kallakury B, Davidson B, Furth P
Disease Models & Mechanisms 2018;11(1)
Disease Models & Mechanisms 2018;11(1)
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
Barton V, D'Amato N, Gordon M, Lind H, Spoelstra N, Babbs B, Heinz R, Elias A, Jedlicka P, Jacobsen B, Richer J
Molecular Cancer Therapeutics 2015;14(3):769-778
Molecular Cancer Therapeutics 2015;14(3):769-778
No comments: Submit comment
No validations: Submit validation data